ArticleAlimentary pharmacology & therapeutics2022

Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B: week 144 results from a real-world, multi-centre cohort study.

Eiichi Ogawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.